JENNIFER L KUDELKO
Allopathic & Osteopathic Physicians|Internal Medicine LARGO, FL NPI 1922097955
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine FL GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$13,035.19
- Category: General Payments
- Program years: PY2018–2024
- Record count: 783
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,086.90 across 101 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,086.90 | 101 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $365.91 | 14 |
| Amgen Inc. | $294.28 | 19 |
| Janssen Biotech, Inc. | $238.46 | 10 |
| ABBVIE INC. | $212.43 | 10 |
| Novo Nordisk AS | $164.34 | 11 |
| Fresenius Kabi USA, LLC | $140.84 | 7 |
| Phathom Pharmaceuticals, Inc. | $137.04 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69.39 | 3 |
| Renalytix AI, Inc. | $59.18 | 3 |
| UCB, Inc. | $58.79 | 4 |
| Lilly USA, LLC | $52.17 | 3 |
| Acerta Pharma LLC | $43.48 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $38.44 | 2 |
| Abbott Laboratories | $34.33 | 2 |
| Janssen Pharmaceuticals, Inc | $30.45 | 2 |
| PFIZER INC. | $29.91 | 2 |
| Edwards Lifesciences Corporation | $28.78 | 1 |
| Aurinia Pharma U.S., Inc. | $22.83 | 1 |
| Ultragenyx Pharmaceutical Inc. | $19.48 | 1 |
| Kiniksa Pharmaceuticals International, plc | $16.71 | 1 |
| DEXCOM, INC. | $16.44 | 1 |
| SOBI, INC | $13.22 | 1 |
By program year
Records — PY2024 (101)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.